NAVLE Gastrointestinal and Digestive

Feline Inflammatory Bowel Disease Study Guide

📅 March 28, 2026 ⏱ 25 min read

Inflammatory bowel disease (IBD) is a chronic gastrointestinal disorder characterized by persistent or recurrent gastrointestinal signs and histologic evidence of mucosal inflammation.

Overview and Clinical Importance

Inflammatory bowel disease (IBD) is a chronic gastrointestinal disorder characterized by persistent or recurrent gastrointestinal signs and histologic evidence of mucosal inflammation. IBD represents one of the most common causes of chronic vomiting, diarrhea, and weight loss in cats. The disease results from complex interactions between environmental factors (dietary antigens, intestinal microbiota), genetic susceptibility, and dysregulated mucosal immune responses. Understanding the pathophysiology, diagnosis, and management of feline IBD is essential for NAVLE success.

IBD is considered idiopathic, meaning the exact underlying cause cannot be identified. However, current evidence suggests a breakdown in mucosal tolerance to normal luminal antigens, including commensal bacteria and dietary components. This leads to chronic intestinal inflammation that disrupts normal absorptive processes.

IBD Type	Predominant Cell Type	Clinical Notes
Lymphocytic-Plasmacytic Enteritis (LPE)	Lymphocytes and plasma cells	MOST COMMON form; Siamese may be predisposed
Eosinophilic Enteritis/Gastroenteritis	Eosinophils (may be mixed)	Second most common; consider food allergy and parasites
Neutrophilic Enteritis	Neutrophils	Rare; associated with Campylobacter species infection
Granulomatous Enteritis	Macrophages/histiocytes	Rare; similar to regional enteritis in humans

Etiology and Pathophysiology

The pathogenesis of feline IBD involves a loss of immune tolerance to enteric antigens in genetically susceptible cats. The normal intestinal mucosa serves as a barrier controlling antigen exposure to gut-associated lymphoid tissue (GALT). When this barrier function fails, inappropriate immune responses develop against harmless antigens such as commensal bacteria and food components.

Key Pathophysiologic Mechanisms

Mucosal inflammation: Disrupts normal absorptive processes causing malabsorption and osmotic diarrhea
Altered gut permeability: Results in leakage of fluid, protein, and blood into the gut lumen
Malabsorbed nutrients: Fats, carbohydrates, and bile acids cause secretory diarrhea
Altered motility: Prostaglandins and leukotrienes affect intestinal smooth muscle
Dysbiosis: Increased populations of Enterobacteriaceae linked to clinical signs and histopathologic lesions

High-YieldFeline IBD is a diagnosis of EXCLUSION. You must rule out parasitic infections, dietary sensitivity, infectious diseases, hyperthyroidism, renal disease, and alimentary lymphoma before making this diagnosis.

Region Affected	Primary Clinical Signs	Additional Features
Small Intestine	Vomiting, weight loss (MOST COMMON), decreased appetite	Diarrhea less frequent than expected; some cats have increased appetite
Large Intestine	Hematochezia, mucoid feces, tenesmus, increased frequency	Small volume diarrhea with urgency
Stomach	Chronic vomiting (most common sign in cats with IBD)	May vomit hairballs more than once monthly

Classification of Feline IBD

IBD is classified by the region of the GI tract affected and the predominant inflammatory cell type infiltrating the mucosa.

Anatomic Classification

Gastritis: Inflammation of the stomach
Enteritis: Inflammation of the small intestine (most common site)
Colitis: Inflammation of the large intestine

Test	Purpose and Expected Findings
CBC	Usually nonspecific; may show eosinophilia (eosinophilic IBD), mild anemia (chronic disease), or neutrophilia
Chemistry Panel	Rule out renal disease, hepatic disease; may see hypoproteinemia, hyperglobulinemia, elevated liver enzymes (if triaditis)
Total T4	Rule out hyperthyroidism (common cause of weight loss and vomiting in older cats)
Urinalysis	Rule out chronic kidney disease
Fecal Examination	Multiple fecal flotations, direct smear; consider fenbendazole trial for occult Giardia
Retroviral Testing	FeLV/FIV status should be known for all cats with chronic illness

Clinical Presentation

Signalment

Age: Middle-aged to older cats (5-8 years most common), but can occur in cats as young as 6 months
Breed: No clear predisposition; Siamese may be predisposed to lymphocytic-plasmacytic enteritis
Sex: No sex predilection

Clinical Signs by GI Tract Region

NAVLE TipOn the NAVLE, weight loss is the MOST COMMON clinical sign in cats with IBD, followed by vomiting, then anorexia, then diarrhea. Many owners fail to notice gradual weight loss. Cats typically lose muscle tissue first and may develop significant sarcopenia.

Physical Examination Findings

Body condition: Thin body condition, muscle wasting (sarcopenia)
Abdominal palpation: Thickened, "ropey" intestinal loops (nonspecific finding)
Coat quality: Poor haircoat, unkempt appearance
Note: Physical examination may be unremarkable in many cats

Finding	Suggests Disease In	Clinical Significance
Low Cobalamin (B12)	Distal small intestine (ileum) or pancreas	Common in IBD; supplement if deficient; half-life only 5-12 days in cats with IBD
Low Folate	Proximal small intestine (jejunum)	Indicates proximal SI disease
Low B12 + High Folate	Small intestinal bacterial overgrowth (SIBO)	Bacteria synthesize folate and bind B12

Diagnostic Approach

A diagnosis of feline IBD requires a systematic approach to exclude other causes of chronic GI signs. The diagnosis is one of EXCLUSION.

Diagnostic Criteria for Feline IBD

Chronic GI signs (vomiting, diarrhea, weight loss) greater than 3 weeks duration
Incomplete response to dietary trials and anthelmintics
Exclusion of other causes (hyperthyroidism, renal disease, hepatic disease, etc.)
Histopathologic confirmation of intestinal mucosal inflammation on biopsy
Clinical response to immunomodulatory therapy

Minimum Database

Serum Cobalamin (B12) and Folate

Measurement of vitamin B12 and folate is highly recommended in cats with chronic GI disease. These tests help characterize malabsorption and guide therapy.

Abdominal Ultrasound Findings

Ultrasound is a valuable screening tool but findings overlap significantly between IBD and low-grade lymphoma.

Key Ultrasound Findings

Muscularis propria thickening: Most consistent finding in both IBD and low-grade lymphoma
Muscularis:submucosa ratio greater than 1: Suggestive of IBD or lymphoma (normally less than 1)
Preserved wall layering: Characteristic of IBD and low-grade lymphoma
Mesenteric lymphadenopathy: Can occur with both; more common with lymphoma
Normal appearance: Does NOT exclude IBD or lymphoma

NAVLE TipUltrasound CANNOT reliably distinguish IBD from low-grade intestinal lymphoma. Both show muscularis thickening with preserved wall layers. Loss of wall layering and mass formation suggest high-grade lymphoma or adenocarcinoma, NOT typical IBD.

Intestinal Biopsy: The Gold Standard

Histopathology is REQUIRED for definitive diagnosis of IBD. Biopsy samples can be obtained via endoscopy or surgical (full-thickness) biopsy.

High-YieldThe ILEUM is a critical biopsy site! It is commonly affected in cats with IBD and lymphoma. Always biopsy the ileum when possible. Full-thickness biopsies are preferred for differentiating IBD from lymphoma because lymphocyte invasion of the muscularis is highly specific (96%) for lymphoma.

WSAVA Histopathologic Grading

The World Small Animal Veterinary Association (WSAVA) developed standardized criteria for histopathologic assessment:

Grade 0: Normal
Grade 1: Mild inflammation
Grade 2: Moderate inflammation
Grade 3: Severe inflammation

Histopathologic Features Assessed

Epithelial injury and intraepithelial lymphocytes
Villus blunting, fusion, and atrophy
Crypt distension and hyperplasia
Lamina propria cellular infiltrate (type and degree)
Lacteal dilation
Fibrosis

Feature	Endoscopic Biopsy	Full-Thickness Surgical Biopsy
Invasiveness	Less invasive	More invasive (laparotomy or laparoscopy)
Tissue Depth	Mucosa and submucosa only	All layers including muscularis
Accessibility	Stomach, duodenum, colon; ileum difficult	Entire GI tract including jejunum and ileum
Best For	Initial diagnosis; mucosal disease	Differentiating IBD from lymphoma; muscularis assessment

Differentiating IBD from Low-Grade Intestinal Lymphoma

This is one of the most challenging diagnostic dilemmas in feline gastroenterology. Low-grade intestinal T-cell lymphoma (LGITL) can be almost impossible to distinguish from severe lymphocytic IBD using histopathology alone.

PARR (PCR for Antigen Receptor Rearrangement)

PARR testing evaluates clonality of lymphocyte populations. Neoplastic cells show monoclonal rearrangement while inflammatory infiltrates remain polyclonal.

Sensitivity: 89-95% for T-cell lymphoma
Specificity: High but limited by false positives in clinically healthy older cats
Key Point: PARR COMPLEMENTS but does not replace histopathology and immunohistochemistry

Feature	IBD (LPE)	Low-Grade Lymphoma
Cell Population	Heterogeneous (mixed T and B cells)	Monomorphic (usually T-cells)
Epitheliotropism	Usually absent or mild	Nests/plaques of lymphocytes in epithelium (50% of cases)
Depth of Infiltration	Mucosal only (89% of cases)	Transmural; muscularis invasion highly specific
Lamina Propria Fibrosis	Superficial fibrosis common (94%)	Usually absent
PARR Testing	Polyclonal	Monoclonal or oligoclonal

Feline Triaditis

Triaditis describes the concurrent presence of IBD, cholangitis/cholangiohepatitis, and pancreatitis in cats. Prevalence is 17-39% in ill referral patients.

Anatomic Predisposition in Cats

Pancreatic duct joins common bile duct BEFORE entering duodenal papilla
Short small intestine with high bacterial load
Increased risk of bacterial reflux and ascending infection

NAVLE TipOn the NAVLE, when you see a cat with IBD symptoms PLUS elevated liver enzymes (ALT, ALP) and/or elevated fPLI (pancreatic lipase), think TRIADITIS. Always evaluate the pancreas and liver in cats with suspected IBD.

Drug	Dosage	Mechanism	Notes
Prednisolone	1-3 mg/kg PO q24h; taper once controlled	Anti-inflammatory immunosuppression	MAINSTAY of therapy; use prednisolone NOT prednisone in cats
Budesonide	0.5-0.75 mg/cat PO q24h	Locally-acting steroid; high first-pass metabolism	For cats intolerant of systemic steroids or diabetic cats
Metronidazole	10-15 mg/kg PO q12h (max 3 weeks)	Antibiotic, antiprotozoal, immunomodulatory	Bitter taste; may cause anorexia
Chlorambucil	2 mg/cat PO q48-72h	Alkylating agent; immunosuppressive	For severe/refractory IBD or if lymphoma cannot be excluded; monitor CBC
Cobalamin (B12)	250 mcg SQ weekly x 6 weeks	Vitamin supplementation	ESSENTIAL if deficient; improves clinical signs regardless of cause

Treatment of Feline IBD

Management involves a multimodal approach including dietary modification, pharmacotherapy, and nutritional support. Treatment is typically lifelong with the goal of controlling clinical signs.

Dietary Management

Dietary therapy is often the first-line treatment for feline IBD. Up to 50% of cats with chronic GI disease may be food-responsive!

Novel protein diet: Rabbit, duck, venison - proteins the cat has never eaten
Hydrolyzed protein diet: Proteins broken down so immune system does not recognize them
Highly digestible diet: Reduces antigen load and limits intestinal inflammation
Duration: Minimum 8-12 weeks for true food trial; improvement may occur within 1-2 weeks
Strict compliance: NO treats, table scraps, or flavored medications during trial

Pharmacotherapy

Treatment Algorithm

Dietary trial: Novel protein or hydrolyzed diet for 2-4 weeks minimum
If partial response: Add metronidazole (especially if pancreatic involvement suspected)
If no response or confirmed IBD: Start prednisolone 1-3 mg/kg PO q24h
Once controlled: Taper steroids every 3-4 weeks to lowest effective dose
If refractory or uncertain diagnosis: Add chlorambucil; re-evaluate for lymphoma
Throughout: Supplement cobalamin if deficient

Prognosis

Food-responsive cats: Excellent prognosis; can be maintained on appropriate diet long-term
Steroid-responsive IBD: Good prognosis; most cats respond well to prednisolone
Severe/refractory IBD: Guarded prognosis; may require lifelong immunosuppression
Low-grade lymphoma: Actually good prognosis! Median survival greater than 2 years with prednisolone and chlorambucil
Key point: Intermittent flare-ups are common and expected; owners should be counseled that IBD is a chronic, manageable condition

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →